Condition

Ulcerative Colitis

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 46 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials46
Recruiting7
Common interventions25
Lead sponsors shown15
Advertisement

Clinical trials

46 shown
Patient Preference for Subcutaneous vs. Intravenous Immune TherapyNCT07223424 · 2025-11-04
RECRUITING
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b StudyNCT06937086 · 2025-06-26
RECRUITING
Safety and Efficacy of Capsule FMT in Treatment-naïve Patients With Newly Diagnosed Chronic Inflammatory DiseasesNCT04924270 · 2023-12-13
RECRUITING
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint InhibitorsNCT04751396 · 2022-04-20
RECRUITING
Evolution and Treatments of Chronic Inflammatory Systemic DiseasesNCT04191395 · 2019-12-11
RECRUITING
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVONCT03816345 · 2019-07-16
RECRUITING
Safety and Efficacy of Fecal Microbiota TransplantationNCT04014413 · 2019-07-15
RECRUITING
Emerging Indications for Hyperbaric Oxygen TreatmentNCT07240649 · 2026-11-01
NOT_YET_RECRUITING
Determine PK Profiles of Ozanimod and Its' Major Metabolites in Healthy SubjectsNCT06528665 · 2025-02-10
COMPLETED
Estimation of Cardiovascular Risk in Patients With Crohn's Disease and Ulcerative Colitis (PROVACI)NCT07095634 · 2025-02-07
ENROLLING_BY_INVITATION
Machine Learning Approach to Study the Interactions Between Environment and Intestinal Tissue Homeostasis in IBDNCT06120322 · 2023-11-01
UNKNOWN
A Study of Endoscopic Sleeve Gastroplasty for Obesity in Ulcerative ColitisNCT05739162 · 2023-09-20
ACTIVE_NOT_RECRUITING
The Evaluation of Injection Site Pain and Adherence in Patients Switching From a Low To High Concentration Adalimumab (AVT-02) Across Multiple Indications.NCT05913817 · 2023-01-09
COMPLETED
Evaluation of the SIMBA Capsule for Small Intestinal DysbiosisNCT05633706 · 2023-01-09
ACTIVE_NOT_RECRUITING
A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune DiseaseNCT06587828 · 2023-01-03
COMPLETED
SAPHIR : Assessment of Predictive Factors for Persistence of Treatment After Initiation of Adalimumab With a Biosimilar (Adalimumab Fresenius KaBI or Substitution of Reference Adalimumab With the Fresenius Kabi Adalimumab Biosimilar in Patients With Chronic Inflammatory DiseasesNCT05598684 · 2022-11-24
UNKNOWN
Systems Biology of Gastrointestinal and Related DiseasesNCT05579444 · 2022-11-11
TERMINATED
Monitoring of Inflammatory ConditionsNCT05458531 · 2022-06-28
COMPLETED
Yuflyma® (Adalimumab), Patient Experience After SwitchingNCT05427942 · 2022-06-03
UNKNOWN
bIosimilar of aDalimumab, an European evAluationNCT05190484 · 2022-04-30
UNKNOWN
The Effect of MedicijnWijs on Adherence to Azathioprine Therapy in Adolescents With IBDNCT05321485 · 2022-03-16
UNKNOWN
Quest to Analyze One Thousand Humans MeditatingNCT06583395 · 2021-12-05
ENROLLING_BY_INVITATION
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research InitiativesNCT05635266 · 2021-10-26
UNKNOWN
The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech RepublicNCT05098600 · 2021-10-15
COMPLETED
Vaccine Response to COVID-19 Vaccines in Patients Using Immunosuppressive MedicationNCT04798625 · 2021-02-15
ACTIVE_NOT_RECRUITING
The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia AreataNCT04239521 · 2020-10-01
COMPLETED
A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic ResponseNCT05051943 · 2020-09-29
COMPLETED
Predicting Medication Response for Autoimmune DiseaseNCT04995783 · 2020-09-01
TERMINATED
Comparison of PK and Tolerability of MSB11022 Administered by AI or PFSNCT04018599 · 2019-07-15
COMPLETED
Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune DiseaseNCT03656627 · 2019-06-27
TERMINATED
Cell Surface Marker Expression in Autoimmune DiseasesNCT03757065 · 2019-06-12
COMPLETED
The Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort StudyNCT03835780 · 2019-02-01
COMPLETED
Outcomes Mandate National Integration With Cannabis as MedicineNCT03944447 · 2018-12-01
UNKNOWN
Comparative Effectiveness and Safety of Biosimilar and Legacy DrugsNCT03729674 · 2018-11-26
UNKNOWN
The Norwegian Drug Monitoring StudyNCT03074656 · 2017-03-01
COMPLETED
National Observational Study On The Use Of Inflectra™ An Infliximab Biosimilar In Real LifeNCT02925338 · 2016-10-19
COMPLETED
Patient-Centred Innovations for Persons With Multimorbidity - QuebecNCT02789800 · 2016-04-22
COMPLETED
Post-marketing Observational Study to Evaluate the Incremental Impact of AbbVie's Patient Support Program on Patient Reported Outcomes and Health Resource Utilization in Inflammatory Arthritis, Psoriasis and Inflammatory Bowel Diseases in Hungary (VALUE)NCT02750800 · 2016-04-07
COMPLETED
Patient-Centred Innovations for Persons With Multimorbidity - OntarioNCT02742597 · 2016-01-12
COMPLETED
The NOR-SWITCH StudyNCT02148640 · 2014-10-01
COMPLETED
Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory DiseasesNCT01988506 · 2014-01-06
COMPLETED
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsNCT01931644 · 2013-07-01
COMPLETED
Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical PracticeNCT01768858 · 2013-02-05
COMPLETED
Prognostic Indicators as Provided by the EPIC ClearViewNCT01476995 · 2010-09-01
COMPLETED
Spontaneous Coronary Artery Dissection (SCAD) and AutoimmunityNCT03941184 · 1995-01-01
COMPLETED
Expanded Access to UpadacitinibNCT04159597
AVAILABLE

Common interventions

AdalimumabDRUG2NivolumabDRUG2100% OxygenDRUG140 mg MSB11022DRUG1AbbVie Care 2.0BEHAVIORAL1AdalimumabBIOLOGICAL1Advanced multi-component meditation practiceBEHAVIORAL1Apollo Endoscopic Suture SystemDEVICE1AVT02 (Alvotech Biosimilar to Adalimumab)BIOLOGICAL1Best PracticeOTHER1BiosimilarDRUG1Biosimilar infliximabDRUG1Biospecimen CollectionPROCEDURE1CabozantinibDRUG1Cannabis, MedicalDRUG1Companion blood samples with procedurePROCEDURE1Coral FRS testDIAGNOSTIC_TEST1DIMAC02BEHAVIORAL1Educational InterventionOTHER1Environmental factor monitoring; collection of blood, feces and urine. For UC: collection of 8 additional biopsiesOTHER1Exposure of interestOTHER1Exposure of interest (studies 2 & 3).OTHER1Faecal microbiota transplantationBIOLOGICAL1Fecal Microbiota TransplantationPROCEDURE1fluid biopsy capsuleDEVICE1

Trial status mix

COMPLETED21
UNKNOWN8
RECRUITING7
ACTIVE_NOT_RECRUITING3
TERMINATED3
ENROLLING_BY_INVITATION2
AVAILABLE1
NOT_YET_RECRUITING1

Phase mix

NA6
PHASE24
PHASE13
PHASE42
PHASE31
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.